Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

Taking runner-up spots for MG were Owen Hershner in the 1600 at 4:28.87, Wallace in the 300 hurdles at 41.73, Henry Bartlett in the 3200 at 9:51.86 and the 4x400 team Jon Miller, Liam Stalnaker ...

See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.

Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological and molecular drivers behind three inflammatory diseases - rheumatoid ...

Read about Gilead Sciences Inc (GILD:XNAS) stock and today's latest news and financial updates. GILD - Gilead Sciences Inc News | Morningstar Morningstar brands and products ...

A high-level overview of Gilead Sciences, Inc. (GILD) stock. View (GILD) real-time stock price, chart, news, analysis, analyst reviews and more.

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer.

Alternatively, Chester Road is also open and provides access to the park. Function room: Tuke Hall. Parking Information: They have over 70 car parking spaces onsite on a first-come first-served basis.

Stay up-to-date on Gilead Sciences, Inc. Common Stock (GILD) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.

Find the latest historical data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.